help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology Vol. 4, No. 2 341-348
doi:10.1210/mend-4-2-341
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Byravan, S.
Right arrow Articles by Stallcup, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Byravan, S.
Right arrow Articles by Stallcup, M. R.

Glucocorticoid-Dependent Maturation of Mouse Mammary Tumor Virus Glycoproteins in Mouse Lymphoma Cells: Isolation of Variants with Constitutive Viral Protein Maturation and Normal Glucocorticoid Receptor Function

Sujatha Byravan* and Michael R. Stallcup

Departments of Pathology and Biochemistry, University of Southern California School of Medicine Los Angeles, California 90033

Address requests for reprints to: Michael R. Stallcup, Department of Pathology, HMR 301, University of Southern California School of Medicine, 2011 Zonal Avenue, Los Angeles, California 90033.

Abstract

The posttranslational maturation and cell surface localization of mouse mammary tumor virus (MMTV) envelope glycoproteins is regulated by glucocorticoid hormone in mouse T-lymphoma cell line W7MG1. Only when the cells are cultured with glucocorticoid is the MMTV envelope precursor, Pr74, converted efficiently to the two mature proteolytic products, gp52 and gp33. By immunological selection we have isolated protein-processing variants that express the mature viral proteins constitutively on the cell surface. The rate of synthesis of Pr74 is indistinguishable in variant and wild-type cells, but the variants efficiently convert Pr74 to gp52 and gp33 even when grown without the hormone. The variant phenotype persists when the variant cells are fused with uninfected wild-type cells to form somatic cell hybrids, indicating that the variant phenotype resulted from expression of a new or altered function that is not expressed in wild-type cells grown without glucocorticoid. Although the specific gene whose structure or regulation is altered in the variant has not yet been determined, some possibilities have been eliminated. First, the number and function of the glucocorticoid receptors in the variant cells was normal, suggesting that alterations in this protein were not responsible for the variant phenotype. Second, comparison by two-dimensional gel electrophoresis of gp52 produced in variant and wild-type cells revealed no differences in size or charge, indicating no gross differences in the processing of the viral proteins in the variant and wildtype cells.

FOOTNOTES

This work was supported by USPHS Grant GM-36317 from the NIGMS, Research Career Development Award CA-01149 from the NCI (to M.R.S.), and American Cancer Society Grant BC-670.

* Predoctoral student in the Department of Biological Sciences at the University of South Carolina, Columbia.

Received for publication August 21, 1989. Revision received October 30, 1989. Accepted for publication November 6, 1989.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society